Study to Investigate the Effects of Talampanel on the Heart Rhythm

Study Title

A Phase 1 Study to Investigate the Effects of Talampanel on the Heart Rhythm

Teva Identifier

TAL-TQT-101 | R09-0539

ClinicalTrials.gov Identifier

NCT00964730

Study Status

Completed

Trial Condition(s)

Healthy

Interventions

Drug: Talampanel | Drug: Moxifloxacin | Drug: Placebo

Study Description

Please refer to ClinicalTrials.gov for a description of the trial
Click for participation criteria and map of study locations
disease icon for clinical trials

Key Participation Requirements

Gender

Female, Male

Age Range

18 Years to 50 Years

Trial Duration

10/01/2009 - 02/01/2010

Phase

Phase 1

Study Type

Interventional